|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
752 |
$69,755.52 |
3.53% |
| Align Technology, Inc. |
ALGN |
016255101 |
338 |
$62,536.76 |
3.16% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$55,422.91 |
2.80% |
| Penumbra, Inc. |
PEN |
70975L107 |
163 |
$54,029.61 |
2.73% |
| Masimo Corporation |
MASI |
574795100 |
294 |
$52,417.26 |
2.65% |
| Waters Corporation |
WAT |
941848103 |
159 |
$50,727.35 |
2.57% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,985 |
$49,821.20 |
2.52% |
| Alcon Inc. |
ALC.SW |
H01301128 |
589 |
$47,309.48 |
2.39% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,046 |
$46,476.44 |
2.35% |
| Teleflex Incorporated |
TFX |
879369106 |
356 |
$46,358.32 |
2.35% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
576 |
$45,532.80 |
2.30% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
99 |
$45,349.92 |
2.29% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,550 |
$45,070.99 |
2.28% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
393 |
$44,229.11 |
2.24% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
163 |
$43,979.03 |
2.23% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
599 |
$43,846.80 |
2.22% |
| Revvity, Inc. |
RVTY |
714046109 |
482 |
$43,153.46 |
2.18% |
| The Cooper Companies, Inc. |
COO |
216648501 |
622 |
$43,154.36 |
2.18% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
33 |
$42,597.72 |
2.16% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
449 |
$42,556.22 |
2.15% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
196 |
$42,075.04 |
2.13% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
143 |
$41,625.87 |
2.11% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
81 |
$41,796.00 |
2.11% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,415 |
$40,910.60 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
210 |
$40,693.80 |
2.06% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,205 |
$40,541.23 |
2.05% |
| DexCom, Inc. |
DXCM |
252131107 |
654 |
$40,044.42 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
180 |
$39,594.60 |
2.00% |
| Stryker Corporation |
SYK |
863667101 |
117 |
$39,590.46 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
446 |
$38,199.90 |
1.93% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
539 |
$37,783.90 |
1.91% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
157 |
$37,599.03 |
1.90% |
| Agilent Technologies, Inc. |
A |
00846U101 |
312 |
$36,894.00 |
1.87% |
| Becton, Dickinson and Company |
BDX |
075887109 |
228 |
$35,298.96 |
1.79% |
| Baxter International Inc. |
BAX |
071813109 |
1,939 |
$35,173.46 |
1.78% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,540 |
$35,268.77 |
1.78% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
778 |
$35,153.22 |
1.78% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,560 |
$35,197.18 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
156 |
$35,056.32 |
1.77% |
| BioMerieux |
BIM.FP |
F1149Y232 |
320 |
$34,346.96 |
1.74% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
485 |
$33,139.54 |
1.68% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,434 |
$30,824.87 |
1.56% |
| Abbott Laboratories |
ABT |
002824100 |
321 |
$30,645.87 |
1.55% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,487 |
$29,090.95 |
1.47% |
| Boston Scientific Corporation |
BSX |
101137107 |
446 |
$28,285.32 |
1.43% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
860 |
$28,107.68 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
229 |
$27,845.20 |
1.41% |
| Insulet Corporation |
PODD |
45784P101 |
135 |
$27,198.45 |
1.38% |
| US Dollar |
$USD |
|
3,951 |
$3,950.98 |
0.20% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|